Literature DB >> 7097945

Risk factors for development of toxic shock syndrome. Association with a tampon brand.

W F Schlech, K N Shands, A L Reingold, B B Dan, G P Schmid, N T Hargrett, A Hightower, L A Herwaldt, M A Neill, J D Band, J V Bennett.   

Abstract

In September 1980, we interviewed by telephone 50 patients with menstrually associated toxic shock syndrome (TSS) who had onset of illness in July or August 1980. These women were asked to provide information about the type of menstrual sanitary products used during the menstrual period associated with their illness. We also interviewed 150 age-matched control subjects, who were asked the same questions for the menstrual period that occurred in the same month as the illness of the matched case. All 50 cases, but only 125 of 150 controls, used tampons. Among women using tampons, cases were more likely to have used Rely brand tampons when compared with controls. No differences were found between cases and controls in the absorbency of tampon products used. No other factors studied through analysis of a follow-up questionnaire mailed five months after the first study were found to be significantly associated with the development of menstrually associated TSS.

Entities:  

Mesh:

Year:  1982        PMID: 7097945

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  14 in total

1.  Investigation by syringe method of effect of tampons on production in vitro of toxic shock syndrome toxin 1 by Staphylococcus aureus.

Authors:  A C Lee; B A Crass; M S Bergdoll
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

2.  Application of cross-linked carboxymethyl cellulose degradation by beta-glucosidase and vaginal microbes to toxic shock syndrome.

Authors:  M R Sierks; P J Reilly
Journal:  Appl Environ Microbiol       Date:  1985-09       Impact factor: 4.792

Review 3.  Toxic shock syndrome.

Authors:  J K Todd
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

4.  Toxic shock syndrome due to occult postoperative wound infection.

Authors:  M J Bresler
Journal:  West J Med       Date:  1983-11

5.  Toxic shock syndrome: chronology of state and federal epidemiologic studies and regulatory decision-making.

Authors:  M E Donawa; G R Schmid; M T Osterholm
Journal:  Public Health Rep       Date:  1984 Jul-Aug       Impact factor: 2.792

6.  Investigation by improved syringe method of effect of tampons on production in vitro of toxic shock syndrome toxin 1 by Staphylococcus aureus.

Authors:  A C Wong; S A Downs
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

7.  Production of toxic shock syndrome toxin 1 by Staphylococcus aureus requires both oxygen and carbon dioxide.

Authors:  R A Ross; A B Onderdonk
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

8.  Production of toxic shock syndrome toxin 1 by Staphylococcus aureus as determined by tampon disk-membrane-agar method.

Authors:  R N Robbins; R F Reiser; G L Hehl; M S Bergdoll
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

Review 9.  Device-Associated Menstrual Toxic Shock Syndrome.

Authors:  Patrick M Schlievert; Catherine C Davis
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

10.  Toxic shock syndrome: clinical and laboratory findings in 30 patients.

Authors:  A W Chow; C K Wong; A M MacFarlane; K H Bartlett
Journal:  Can Med Assoc J       Date:  1984-02-15       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.